Asthma Clinical Trial
Official title:
Parents, Pediatricians, and Telephone Coaches Partner to Improve Control of Asthma
Parents of children with asthma must work with their child's pediatrician to ensure that their child's asthma is managed well. Asthma coaches are one way to facilitate and support the relationship between parents and pediatricians. This study will evaluate whether access to a 12-month telephone asthma coaching program for parents is an effective way to improve asthma outcomes in children.
Asthma is the most common long-term disease among children. Each year, most children with
asthma will have at least one asthma exacerbation, experience asthma symptoms on
approximately 100 days, and miss 4 days of school because of asthma. Surveys of primary care
physicians (PCPs) and asthma patients have indicated that asthma care is episodic, effective
asthma controller medications are underused, and few PCPs provide self-management education
or support for parents of children with asthma. Previous research showed that when an asthma
coach worked with parents of children from low-income, urban neighborhoods, there were
multiple benefits: improved self-management behaviors, reduced asthma hospitalizations, and
improved rates of follow-up with a PCP after an emergency department visit for asthma
symptoms. In this study, researchers will evaluate the effectiveness of an asthma coach
program in a larger, general asthma population. Trained asthma coaches will work with parents
of children with asthma to provide education about the goals of asthma care, and they will
encourage and facilitate an active partnership between the family and PCP to enhance asthma
care and improve self-management behaviors. Study researchers will then evaluate the
effectiveness of this program at improving asthma control and quality of life among children
with asthma. The cost effectiveness of the program will also be analyzed.
This study will enroll pediatricians and parents of children between 5 and 12 years old who
have persistent asthma. Pediatricians will be randomly assigned to either the asthma coach
program or usual care. All pediatricians will receive access to the Education in Quality
Improvement for Pediatric Practice (eQIPP) module for asthma care provided by the American
Academy of Pediatrics. They will also receive articles about effective doctor-parent
communication on asthma and asthma billing practices. In addition, pediatricians taking part
in the asthma coach program will attend two meetings to learn about asthma coaching and how
the program can be implemented into their practice. For 12 months, an asthma coach will work
directly with the parents of children who see doctors participating in the asthma coaching
group. Telephone calls with the asthma coach will be arranged at times convenient for the
parent and will occur anywhere between once a week to once a month. At Months 12 and 24,
about 40 parents of children in each pediatrician's practice will participate in telephone
interviews and their children's medical charts will be reviewed to assess asthma control,
asthma-related quality of life factors, and urgent care events.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|